What are the side effects of TKI inhibitors
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
- Last updated June 3, 2026. Informational only — not a substitute for your oncology team.
Side Effects of TKI Inhibitors
Tyrosine kinase inhibitors (TKIs) are targeted cancer drugs that work by blocking specific proteins that help cancer cells grow. While they're effective treatments—especially for chronic myeloid leukemia (CML)—they can cause side effects that vary depending on which TKI you're taking.
Common Side Effects by Category
Blood-Related Side Effects (Hematologic)
According to the NCCN Guidelines for CML, cytopenias (low blood cell counts) are among the most common side effects:
- Anemia (low red blood cells) - causes fatigue and shortness of breath
- Neutropenia (low white blood cells) - increases infection risk
- Thrombocytopenia (low platelets) - increases bleeding and bruising risk
These are usually managed with temporary breaks from the medication or dose reductions. Your doctor may also recommend blood transfusions or growth factor support if needed.
Gastrointestinal (Stomach/Digestive) Side Effects
These are very common and vary by TKI type:
- Diarrhea - ranges from 16-75% depending on the drug
- Nausea and vomiting - 9-42% of patients
- Constipation - 10-23% of patients
Management tip: Taking your TKI with food and a large glass of water can help reduce stomach upset. Your doctor may recommend anti-diarrheal medications or dietary changes.
Muscle and Bone Side Effects
- Muscle spasms and cramps - particularly common with imatinib (affecting up to 41% of patients)
- Musculoskeletal pain - can significantly affect quality of life
- Bone density loss - especially with long-term imatinib use
These may improve with electrolyte correction (potassium, calcium, phosphate), stretching, adequate hydration, and gentle exercise.
Fluid Retention
- Peripheral edema (swelling in legs/feet) - 1-37% depending on the TKI
- Periorbital edema (puffiness around eyes)
- Weight gain and bloating
Management includes compression stockings and sometimes diuretics (water pills).
Skin and Rash Issues
- Rash - 13-39% of patients
- Dry skin - common with several TKIs
- Skin hypopigmentation (loss of color) - reversible with dose reduction or stopping the drug
Dermatologists can help manage severe cases with moisturizers, antihistamines, or topical steroids.
Cardiovascular (Heart) Side Effects
According to NCCN Guidelines, some TKIs carry cardiovascular risks:
- High blood pressure - 6-16% of patients
- Chest pain or palpitations (irregular heartbeat)
- Arterial or vascular events (blood clots, stroke risk)
- Heart failure - rare but serious
Important: Your doctor should identify cardiovascular risk factors (diabetes, high cholesterol, smoking) before starting treatment and monitor you closely during therapy.
Lung-Related Side Effects
- Pleural effusion (fluid around the lungs) - particularly with dasatinib (up to 28%)
- Pulmonary arterial hypertension (high blood pressure in lung vessels) - rare but serious, more common with dasatinib
- Pneumonitis (lung inflammation) - rare
These require holding the medication and sometimes switching to a different TKI.
Liver and Kidney Issues
- Elevated liver enzymes (ALT/AST) - 2-34% depending on the drug
- Kidney function changes - can occur with long-term use
- Jaundice (yellowing of skin/eyes) - rare
Your doctor will monitor blood tests regularly to catch these early.
Other Side Effects
- Fatigue - 8-25% of patients, often related to muscle pain
- Headaches - 8-34% of patients
- High blood sugar - 4-9% of patients
- Pancreatitis (pancreas inflammation) - rare but serious
How Side Effects Vary by TKI Type
Different TKIs have different side effect profiles. For example:
- Dasatinib: Higher rates of pleural effusion and pulmonary hypertension
- Bosutinib: More diarrhea and liver enzyme elevation
- Nilotinib: More rash and headaches
- Imatinib: More muscle spasms and bone density loss
- Asciminib: Generally fewer side effects overall
Managing Side Effects
According to NCCN Guidelines, your care team can:
- Adjust your dose - taking less medication while maintaining disease control
- Take temporary breaks - pausing treatment briefly to let side effects resolve
- Switch to a different TKI - if side effects are unmanageable with one drug
- Provide supportive care - medications, supplements, or lifestyle changes to manage specific symptoms
- Monitor closely - regular blood tests and check-ins to catch problems early
Important Points to Remember
- Side effects don't mean the drug isn't working - many patients have good disease control even with side effects
- Most side effects are manageable - your care team has many strategies to help
- Adherence matters - taking your medication as prescribed is crucial for treatment success, so reporting side effects early helps your doctor adjust your plan
- Individual variation - what happens to one patient may not happen to another
Questions to Ask Your Doctor
- Which TKI are you recommending, and why?
- What side effects should I watch for specifically?
- When should I call you about a side effect versus managing it at home?
- Are there preventive measures I can take before side effects start?
- If I develop side effects, what are my options (dose adjustment, switching drugs, supportive care)?
- How often will you monitor me with blood tests and physical exams?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with side effects for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Prostate cancer, Gleason 6. Is active surveillance reasonable
TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona
What staging questions should I ask
TL;DR: Staging questions help your doctor understand how far your follicular lymphoma has spread, which directly determines your treatment options and
Just diagnosed with follicular lymphoma. What should I ask my oncologist
TL;DR: Follicular lymphoma is highly treatable, and your first conversation with your oncologist should focus on understanding your specific stage, wh
Prostate cancer, Gleason 6. Is active surveillance reasonable for me
TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona
What questions about staging should I bring up
TL;DR: Staging tells you how advanced your cancer is and helps your doctor plan treatment—ask your team to explain YOUR specific stage and what it mea
Just diagnosed with follicular lymphoma. What should I ask my oncologist at my first appointment
TL;DR: Your first appointment is about understanding your specific type of follicular lymphoma and what tests you need—ask your doctor what stage you
What lifestyle changes are recommended for cancer patients
TL;DR: Lifestyle changes like nutrition, exercise, sleep, and stress management can help support your body during cancer treatment and improve how you
What is the drug for fgfr mytation
Several FDA-approved drugs target FGFR mutations, with pemigatinib and infigratinib being the most commonly used; your doctor will choose based on you